fasudil has been researched along with Wallerian Degeneration in 2 studies
fasudil: intracellular calcium antagonist; structure in first source
fasudil : An isoquinoline substituted by a (1,4-diazepan-1-yl)sulfonyl group at position 5. It is a Rho-kinase inhibitor and its hydrochloride hydrate form is approved for the treatment of cerebral vasospasm and cerebral ischemia.
Wallerian Degeneration: Degeneration of distal aspects of a nerve axon following injury to the cell body or proximal portion of the axon. The process is characterized by fragmentation of the axon and its MYELIN SHEATH.
Excerpt | Relevance | Reference |
---|---|---|
" Injection of 10 microM and 100 microM Y-27632 induced extension of the optic axons beyond the crush site, with the latter dosage giving stronger regeneration." | 1.35 | Differential effects of two ROCK inhibitors, Fasudil and Y-27632, on optic nerve regeneration in adult cats. ( Ichikawa, M; Sagawa, H; Saito, K; Tokita, Y; Watanabe, M; Yoshida, J, 2008) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sun, X | 1 |
Minohara, M | 1 |
Kikuchi, H | 1 |
Ishizu, T | 1 |
Tanaka, M | 1 |
Piao, H | 1 |
Osoegawa, M | 1 |
Ohyagi, Y | 1 |
Shimokawa, H | 1 |
Kira, J | 1 |
Ichikawa, M | 1 |
Yoshida, J | 1 |
Saito, K | 1 |
Sagawa, H | 1 |
Tokita, Y | 1 |
Watanabe, M | 1 |
2 other studies available for fasudil and Wallerian Degeneration
Article | Year |
---|---|
The selective Rho-kinase inhibitor Fasudil is protective and therapeutic in experimental autoimmune encephalomyelitis.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Central Nervous System; Chemotaxis, Leukocyt | 2006 |
Differential effects of two ROCK inhibitors, Fasudil and Y-27632, on optic nerve regeneration in adult cats.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Amides; Animals; Axons; Cats; Cells, Cultured; Dose-R | 2008 |